Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Abcam plc

ABCM•NASDAQ
Healthcare
Biotechnology
$23.99
$0.010(0.04%)
U.S. Market is Open • 12:27

Abcam plc (ABCM) Stock Overview

Explore Abcam plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio-478.66
EPS (TTM)$0.01
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$50.38

ABCM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abcam plc (ABCM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $50.38.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -478.66 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
0.04%
3-Month Change
5.45%
6-Month Change
-0.04%
Year-to-Date (YTD) Change
N/A
1-Year Change
41.12%
3-Year Change
17.20%
5-Year Change
66.29%
All-Time (Max) Change
376.02%

Contact Information

https://www.abcam.com
44 12 2369 6000
Discovery Drive, Cambridge, NaN, CB2 0AX

Company Facts

17,600 Employees
IPO DateOct 22, 2020
CountryGB

Frequently Asked Questions